These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


139 related items for PubMed ID: 17942383

  • 1. Short-term changes in bone and mineral metabolism following gastrectomy in gastric cancer patients.
    Baek KH, Jeon HM, Lee SS, Lim DJ, Oh KW, Lee WY, Rhee EJ, Han JH, Cha BY, Lee KW, Son HY, Kang SK, Kang MI.
    Bone; 2008 Jan; 42(1):61-7. PubMed ID: 17942383
    [Abstract] [Full Text] [Related]

  • 2. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD.
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [Abstract] [Full Text] [Related]

  • 3. Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial.
    Lane NE, Sanchez S, Modin GW, Genant HK, Pierini E, Arnaud CD.
    J Bone Miner Res; 2000 May; 15(5):944-51. PubMed ID: 10804025
    [Abstract] [Full Text] [Related]

  • 4. Osteoprotegerin and bone mass in squamous cell head and neck cancer patients.
    Valero C, Olmos JM, Rivera F, Hernández JL, Vega ME, Macías JG.
    Calcif Tissue Int; 2006 Jun; 78(6):343-7. PubMed ID: 16830204
    [Abstract] [Full Text] [Related]

  • 5. Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal.
    Cosman F, Nieves J, Woelfert L, Formica C, Gordon S, Shen V, Lindsay R.
    J Bone Miner Res; 2001 May; 16(5):925-31. PubMed ID: 11341338
    [Abstract] [Full Text] [Related]

  • 6. Bone mineral density in postmenarchal adolescent girls in the United States: associated biopsychosocial variables and bone turnover markers.
    Harel Z, Gold M, Cromer B, Bruner A, Stager M, Bachrach L, Wolter K, Reid C, Hertweck P, Nelson A, Nelson D, Coupey S, Johnson C, Burkman R, Bone H.
    J Adolesc Health; 2007 Jan; 40(1):44-53. PubMed ID: 17185205
    [Abstract] [Full Text] [Related]

  • 7. Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the MINOS study.
    Szulc P, Munoz F, Marchand F, Chapuy MC, Delmas PD.
    Calcif Tissue Int; 2003 Dec; 73(6):520-30. PubMed ID: 12958693
    [Abstract] [Full Text] [Related]

  • 8. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs.
    Välimäki MJ, Tiihonen M, Laitinen K, Tähtelä R, Kärkkäinen M, Lamberg-Allardt C, Mäkelä P, Tunninen R.
    J Bone Miner Res; 1994 May; 9(5):631-7. PubMed ID: 8053391
    [Abstract] [Full Text] [Related]

  • 9. A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin.
    Välimäki MJ, Kinnunen K, Volin L, Tähtelä R, Löyttyniemi E, Laitinen K, Mäkelä P, Keto P, Ruutu T.
    Bone Marrow Transplant; 1999 Feb; 23(4):355-61. PubMed ID: 10100579
    [Abstract] [Full Text] [Related]

  • 10. Pattern of periprosthetic bone remodeling around stable uncemented tapered hip stems: a prospective 84-month follow-up study and a median 156-month cross-sectional study with DXA.
    Aldinger PR, Sabo D, Pritsch M, Thomsen M, Mau H, Ewerbeck V, Breusch SJ.
    Calcif Tissue Int; 2003 Aug; 73(2):115-21. PubMed ID: 14565592
    [Abstract] [Full Text] [Related]

  • 11. Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study.
    Lange U, Teichmann J, Müller-Ladner U, Strunk J.
    Rheumatology (Oxford); 2005 Dec; 44(12):1546-8. PubMed ID: 16263785
    [Abstract] [Full Text] [Related]

  • 12. Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine.
    Karner I, Hrgović Z, Sijanović S, Buković D, Klobucar A, Usadel KH, Fassbender WJ.
    Eur J Med Res; 2005 Nov 16; 10(11):480-8. PubMed ID: 16354602
    [Abstract] [Full Text] [Related]

  • 13. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.
    Barone A, Giusti A, Pioli G, Girasole G, Razzano M, Pizzonia M, Palummeri E, Bianchi G.
    J Am Geriatr Soc; 2007 May 16; 55(5):752-7. PubMed ID: 17493196
    [Abstract] [Full Text] [Related]

  • 14. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
    Greenspan SL, Parker RA, Ferguson L, Rosen HN, Maitland-Ramsey L, Karpf DB.
    J Bone Miner Res; 1998 Sep 16; 13(9):1431-8. PubMed ID: 9738515
    [Abstract] [Full Text] [Related]

  • 15. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH, Huang TS, Hsieh SJ.
    Miner Electrolyte Metab; 1996 Sep 16; 22(4):219-23. PubMed ID: 8807625
    [Abstract] [Full Text] [Related]

  • 16. Magnesium deficiency and bone loss after cardiac transplantation.
    Boncimino K, McMahon DJ, Addesso V, Bilezikian JP, Shane E.
    J Bone Miner Res; 1999 Feb 16; 14(2):295-303. PubMed ID: 9933485
    [Abstract] [Full Text] [Related]

  • 17. Bone metabolism in cholestatic children before and after living-related liver transplantation--a long-term prospective study.
    Kryskiewicz E, Pawlowska J, Pludowski P, Ismail H, Karczmarewicz E, Teisseyre M, Skorupa E, Ryzko J, Kalicinski P, Socha J, Lorenc RS.
    J Clin Densitom; 2012 Feb 16; 15(2):233-40. PubMed ID: 22154432
    [Abstract] [Full Text] [Related]

  • 18. Evolution of bone disease at 2 years after transplantation: a single-center study.
    Falkiewicz K, Boratyńska M, Zmonarski SC, Milewicz A, Patrzałek D, Biecek P, Klinger M.
    Transplant Proc; 2009 Oct 16; 41(8):3063-6. PubMed ID: 19857677
    [Abstract] [Full Text] [Related]

  • 19. Circulating fibroblast growth factor-23 increases following intermittent parathyroid hormone (1-34) in postmenopausal osteoporosis: association with biomarker of bone formation.
    Sridharan M, Cheung J, Moore AE, Frost ML, Fraser WD, Fogelman I, Hampson G.
    Calcif Tissue Int; 2010 Nov 16; 87(5):398-405. PubMed ID: 20838781
    [Abstract] [Full Text] [Related]

  • 20. Changes in the serum growth factors and osteoprotegerin after bone marrow transplantation: impact on bone and mineral metabolism.
    Baek KH, Lee WY, Oh KW, Kim HS, Han JH, Kang MI, Cha BY, Lee KW, Son HY, Kang SK, Kim CC.
    J Clin Endocrinol Metab; 2004 Mar 16; 89(3):1246-54. PubMed ID: 15001618
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.